Sieve analysis to understand how SARS-CoV-2 diversity can impact vaccine protection.

by Morgane Rolland, Peter B Gilbert
Published 2021-03-01

On modeling HIV and T cells in vivo: assessing causal estimators in vaccine trials.

by W David Wick, Peter B Gilbert, Steven G Self
Published 2006-06-01

chngpt: threshold regression model estimation and inference

by Youyi Fong, Ying Huang, Peter B. Gilbert, Sallie R. Permar
Published 2017-10-01

FCGR2C Polymorphisms Associated with HIV-1 Vaccine Protection Are Linked to Altered Gene Expression of Fc-γ Receptors in Human B Cells.

by Xinxia Peng, Shuying S Li, Peter B Gilbert, Daniel E Geraghty, Michael G Katze
Published 2016-01-01

HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy

by Peter B Gilbert, Youyi Fong, Michal Juraska, Lindsay N Carpp, Arnold S Monto, Emily T Martin, Joshua G Petrie
Published 2019-05-01

Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV prevention.

by Bryan T Mayer, Allan C deCamp, Yunda Huang, Joshua T Schiffer, Raphael Gottardo, Peter B Gilbert, Daniel B Reeves
Published 2022-04-01

HIV-specific probabilistic models of protein evolution.

by David C Nickle, Laura Heath, Mark A Jensen, Peter B Gilbert, James I Mullins, Sergei L Kosakovsky Pond
Published 2007-06-01

Immune-correlates analysis of an HIV-1 vaccine efficacy trial reveals an association of nonspecific interferon-γ secretion with increased HIV-1 infection risk: a cohort-based model...

by Yunda Huang, Ann Duerr, Nicole Frahm, Lily Zhang, Zoe Moodie, Steve De Rosa, M Juliana McElrath, Peter B Gilbert
Published 2014-01-01

Rapidly identifying new coronavirus mutations of potential concern in the Omicron variant using an unsupervised learning strategy

by Lue Ping Zhao, Terry P. Lybrand, Peter B. Gilbert, Thomas H. Payne, Chul-Woo Pyo, Daniel E. Geraghty, Keith R. Jerome
Published 2022-11-01

Application of the SLAPNAP statistical learning tool to broadly neutralizing antibody HIV prevention research

by Brian D. Williamson, Craig A. Magaret, Shelly Karuna, Lindsay N. Carpp, Huub C. Gelderblom, Yunda Huang, David Benkeser, Peter B. Gilbert
Published 2023-09-01

Modeling cumulative overall prevention efficacy for the VRC01 phase 2b efficacy trials

by Yunda Huang, Shelly Karuna, Lindsay N. Carpp, Daniel Reeves, Amarendra Pegu, Kelly Seaton, Kenneth Mayer, Joshua Schiffer, John Mascola, Peter B. Gilbert
Published 2018-09-01

Peptide Targeted by Human Antibodies Associated with HIV Vaccine-Associated Protection Assumes a Dynamic α-Helical Structure.

by Mohammed S Aiyegbo, Evgeny Shmelkov, Lorenzo Dominguez, Michael Goger, Shibani Battacharya, Allan C deCamp, Peter B Gilbert, Phillip W Berman, Timothy Cardozo
Published 2017-01-01

Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection

by David S. Khoury, Timothy E. Schlub, Deborah Cromer, Megan Steain, Youyi Fong, Peter B. Gilbert, Kanta Subbarao, James A. Triccas, Stephen J. Kent, Miles P. Davenport
Published 2023-02-01

Vaccine-Induced Antibodies Mediate Higher Antibody-Dependent Cellular Cytotoxicity After Interleukin-15 Pretreatment of Natural Killer Effector Cells

by Leigh Fisher, Melissa Zinter, Sherry Stanfield-Oakley, Lindsay N. Carpp, R. Whitney Edwards, R. Whitney Edwards, Thomas Denny, Zoe Moodie, Fatima Laher, Linda-Gail Bekker, M. Juliana McElrath, Peter B. Gilbert, Peter B. Gilbert, Lawrence Corey, Georgia Tomaras, Georgia Tomaras, Georgia Tomaras, Georgia Tomaras, Justin Pollara, Justin Pollara, Guido Ferrari, Guido Ferrari, Guido Ferrari
Published 2019-11-01

Tracking SARS-CoV-2 Spike Protein Mutations in the United States (January 2020—March 2021) Using a Statistical Learning Strategy

by Lue Ping Zhao, Terry P. Lybrand, Peter B. Gilbert, Thomas R. Hawn, Joshua T. Schiffer, Leonidas Stamatatos, Thomas H. Payne, Lindsay N. Carpp, Daniel E. Geraghty, Keith R. Jerome
Published 2021-12-01

Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic disease.

by Chloé Pasin, M Elizabeth Halloran, Peter B Gilbert, Edith Langevin, R Leon Ochiai, Punnee Pitisuttithum, Maria Rosario Capeding, Gabriel Carrasquilla, Carina Frago, Margarita Cortés, Laurent Chambonneau, Zoe Moodie
Published 2018-01-01

Pooled-Peptide Epitope Mapping Strategies Are Efficient and Highly Sensitive: An Evaluation of Methods for Identifying Human T Cell Epitope Specificities in Large-Scale HIV Vaccine...

by Andrew Fiore-Gartland, Bryce A Manso, David P Friedrich, Erin E Gabriel, Greg Finak, Zoe Moodie, Tomer Hertz, Stephen C De Rosa, Nicole Frahm, Peter B Gilbert, M Juliana McElrath
Published 2016-01-01

Stochastic interventional approach to assessing immune correlates of protection: Application to the COVE messenger RNA-1273 vaccine trial

by Nima S. Hejazi, Xiaoying Shen, Lindsay N. Carpp, David Benkeser, Dean Follmann, Holly E. Janes, Lindsey R. Baden, Hana M. El Sahly, Weiping Deng, Honghong Zhou, Brett Leav, David C. Montefiori, Peter B. Gilbert
Published 2023-12-01

Microneutralization assay titer correlates analysis in two phase 3 trials of the CYD-TDV tetravalent dengue vaccine in Asia and Latin America.

by Lindsay N Carpp, Youyi Fong, Matthew Bonaparte, Zoe Moodie, Michal Juraska, Ying Huang, Brenda Price, Yingying Zhuang, Jason Shao, Lingyi Zheng, Laurent Chambonneau, Robert Small, Saranya Sridhar, Carlos A DiazGranados, Peter B Gilbert
Published 2020-01-01

Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 Transmission

by David A. Swan, Ashish Goyal, Chloe Bracis, Mia Moore, Elizabeth Krantz, Elizabeth Brown, Fabian Cardozo-Ojeda, Daniel B. Reeves, Fei Gao, Peter B. Gilbert, Lawrence Corey, Myron S. Cohen, Holly Janes, Dobromir Dimitrov, Joshua T. Schiffer
Published 2021-09-01